Thomas Shrader
Stock Analyst at BTIG
(4.11)
# 1,610
Out of 4,592 analysts
710
Total ratings
39.4%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PCVX Vaxcyte | Maintained: Buy | $89 | $55.96 | +59.04% | 27 | Jul 29, 2026 | |
| HROW Harrow | Maintained: Buy | $63 | $38.94 | +61.79% | 11 | Jul 21, 2026 | |
| BIIB Biogen | Maintained: Hold | n/a | $207.93 | - | 51 | Jul 13, 2026 | |
| ANRO Alto Neuroscience | Rated: Buy | $28 | $28.63 | -2.20% | 8 | Jul 13, 2026 | |
| CMPS COMPASS Pathways | Maintained: Buy | $14 → $25 | $11.57 | +116.08% | 15 | Jul 7, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $12 | $3.84 | +212.50% | 7 | Jul 6, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Maintained: Buy | $23 | $5.92 | +288.51% | 11 | Jul 6, 2026 | |
| SER Serina Therapeutics | Initiated Coverage: Buy | $8 | $2.04 | +292.16% | 1 | Jul 1, 2026 | |
| IVVD Invivyd | Maintained: Buy | $10 | $0.5816 | +1,619.39% | 8 | Jun 30, 2026 | |
| NRXP NRx Pharmaceuticals | Maintained: Buy | $25 | $3.12 | +701.28% | 13 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $7.44 | +155.38% | 8 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.76 | +184.09% | 29 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 | $3.49 | +329.80% | 2 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $24.85 | +60.97% | 1 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $24.35 | +60.16% | 37 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $30.04 | +29.83% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.62 | +270.37% | 25 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.17 | +268.66% | 29 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $147 | $74.63 | +96.97% | 6 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.37 | +68.78% | 17 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.60 | +462.50% | 33 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.37 | +237.55% | 7 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $4.08 | +292.16% | 24 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $13.82 | +15.77% | 28 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.77 | - | 32 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $200 | $14.92 | n/a | 7 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.60 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.29 | n/a | 14 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $0.0001 | n/a | 6 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $1.06 | n/a | 16 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.68 | n/a | 5 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $82.14 | n/a | 20 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 → $15 | $11.62 | n/a | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.27 | n/a | 5 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.02 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $216 | $15.56 | n/a | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $87 → $13 | $3.38 | n/a | 5 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $12 | $3.78 | n/a | 8 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.70 | n/a | 4 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $17.52 | n/a | 2 | Mar 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $21.49 | n/a | 4 | Mar 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $57 → $70 | $28.25 | n/a | 5 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.15 | n/a | 4 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $30.40 | n/a | 7 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 7 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $7.00 | n/a | 5 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $5.37 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.000001 | n/a | 3 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 | $0.9872 | n/a | 4 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.34 | n/a | 9 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.13 | n/a | 8 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.18 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $24.82 | n/a | 1 | Oct 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $39 | $5.94 | n/a | 12 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $26 | $7.73 | n/a | 4 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $12 | $32.68 | n/a | 4 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $40 | $10.77 | n/a | 5 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $76 | $55.04 | n/a | 3 | Oct 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.656 | n/a | 17 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $130 | $7.89 | n/a | 7 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $76.98 | n/a | 2 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 | $0.0002 | n/a | 1 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $38 | $6.79 | n/a | 9 | Jun 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.2 → $11 | $3.41 | n/a | 4 | Dec 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $131.28 | n/a | 1 | Mar 23, 2015 |
Vaxcyte
Jul 29, 2026
Maintained: Buy
Price Target: $89
Current: $55.96
Upside: +59.04%
Harrow
Jul 21, 2026
Maintained: Buy
Price Target: $63
Current: $38.94
Upside: +61.79%
Biogen
Jul 13, 2026
Maintained: Hold
Price Target: n/a
Current: $207.93
Upside: -
Alto Neuroscience
Jul 13, 2026
Rated: Buy
Price Target: $28
Current: $28.63
Upside: -2.20%
COMPASS Pathways
Jul 7, 2026
Maintained: Buy
Price Target: $14 → $25
Current: $11.57
Upside: +116.08%
Opus Genetics
Jul 6, 2026
Maintained: Buy
Price Target: $12
Current: $3.84
Upside: +212.50%
Arcturus Therapeutics Holdings
Jul 6, 2026
Maintained: Buy
Price Target: $23
Current: $5.92
Upside: +288.51%
Serina Therapeutics
Jul 1, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $2.04
Upside: +292.16%
Invivyd
Jun 30, 2026
Maintained: Buy
Price Target: $10
Current: $0.5816
Upside: +1,619.39%
NRx Pharmaceuticals
Jun 22, 2026
Maintained: Buy
Price Target: $25
Current: $3.12
Upside: +701.28%
Jun 11, 2026
Maintained: Buy
Price Target: $19
Current: $7.44
Upside: +155.38%
May 26, 2026
Maintained: Buy
Price Target: $5
Current: $1.76
Upside: +184.09%
May 26, 2026
Rated: Buy
Price Target: $15
Current: $3.49
Upside: +329.80%
May 13, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $24.85
Upside: +60.97%
May 11, 2026
Maintained: Buy
Price Target: $39
Current: $24.35
Upside: +60.16%
May 11, 2026
Maintained: Buy
Price Target: $39
Current: $30.04
Upside: +29.83%
Apr 2, 2026
Maintained: Buy
Price Target: $6
Current: $1.62
Upside: +270.37%
Apr 2, 2026
Maintained: Buy
Price Target: $8
Current: $2.17
Upside: +268.66%
Mar 30, 2026
Maintained: Buy
Price Target: $147
Current: $74.63
Upside: +96.97%
Mar 26, 2026
Maintained: Buy
Price Target: $4
Current: $2.37
Upside: +68.78%
Mar 17, 2026
Maintained: Buy
Price Target: $9
Current: $1.60
Upside: +462.50%
Mar 16, 2026
Maintained: Buy
Price Target: $8
Current: $2.37
Upside: +237.55%
Mar 16, 2026
Maintained: Buy
Price Target: $16
Current: $4.08
Upside: +292.16%
Nov 17, 2025
Maintained: Buy
Price Target: $16
Current: $13.82
Upside: +15.77%
Nov 3, 2025
Maintained: Hold
Price Target: n/a
Current: $1.77
Upside: -
Jul 21, 2025
Maintained: Buy
Price Target: $8 → $200
Current: $14.92
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.60
Upside: n/a
Mar 2, 2025
Maintained: Hold
Price Target: n/a
Current: $7.29
Upside: n/a
Mar 19, 2024
Maintained: Buy
Price Target: $32
Current: $0.0001
Upside: n/a
Feb 28, 2024
Maintained: Buy
Price Target: $33
Current: $1.06
Upside: n/a
Jan 5, 2024
Maintained: Buy
Price Target: n/a
Current: $0.68
Upside: n/a
Nov 17, 2023
Rated: Hold
Price Target: n/a
Current: $82.14
Upside: n/a
Nov 14, 2023
Rated: Buy
Price Target: $32 → $15
Current: $11.62
Upside: n/a
Aug 4, 2023
Rated: Hold
Price Target: n/a
Current: $5.27
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $4.02
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $216
Current: $15.56
Upside: n/a
Mar 27, 2023
Maintained: Buy
Price Target: $87 → $13
Current: $3.38
Upside: n/a
Mar 20, 2023
Rated: Buy
Price Target: $50 → $12
Current: $3.78
Upside: n/a
Mar 20, 2023
Reiterated: Hold
Price Target: n/a
Current: $6.70
Upside: n/a
Mar 12, 2023
Rated: Buy
Price Target: $20
Current: $17.52
Upside: n/a
Mar 5, 2023
Maintained: Buy
Price Target: $56
Current: $21.49
Upside: n/a
Mar 2, 2023
Rated: Buy
Price Target: $57 → $70
Current: $28.25
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $1.15
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $30.40
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Sep 9, 2021
Rated: Buy
Price Target: $16
Current: $7.00
Upside: n/a
Aug 6, 2021
Maintained: Buy
Price Target: $60
Current: $5.37
Upside: n/a
Jul 6, 2021
Rated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Jun 10, 2021
Maintained: Buy
Price Target: $5.5
Current: $0.9872
Upside: n/a
Jun 4, 2021
Rated: Hold
Price Target: n/a
Current: $1.34
Upside: n/a
May 10, 2021
Maintained: Hold
Price Target: n/a
Current: $3.13
Upside: n/a
Sep 23, 2020
Downgraded: Hold
Price Target: n/a
Current: $1.18
Upside: n/a
Oct 6, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $24.82
Upside: n/a
Nov 9, 2017
Reiterated: Buy
Price Target: $57 → $39
Current: $5.94
Upside: n/a
Nov 7, 2017
Maintained: Buy
Price Target: $32 → $26
Current: $7.73
Upside: n/a
Nov 1, 2017
Reiterated: Buy
Price Target: $14 → $12
Current: $32.68
Upside: n/a
Oct 17, 2017
Reiterated: Buy
Price Target: $20 → $40
Current: $10.77
Upside: n/a
Oct 10, 2017
Reiterated: Buy
Price Target: $35 → $76
Current: $55.04
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $11
Current: $0.656
Upside: n/a
Oct 2, 2017
Rated: Buy
Price Target: $110 → $130
Current: $7.89
Upside: n/a
Jul 24, 2017
Reiterated: Buy
Price Target: $24
Current: $76.98
Upside: n/a
Jun 30, 2017
Downgraded: Hold
Price Target: $6
Current: $0.0002
Upside: n/a
Jun 21, 2017
Maintained: Buy
Price Target: $32 → $38
Current: $6.79
Upside: n/a
Dec 22, 2016
Reiterated: Hold
Price Target: $1.2 → $11
Current: $3.41
Upside: n/a
Mar 23, 2015
Downgraded: Hold
Price Target: n/a
Current: $131.28
Upside: n/a